Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Bibliographic Details
Main Authors:	van der Pluijm, RW, Peto, TJ, Hamaluba, M, Callery, JJ, Tripura, R, White, NJ, Dondorp, AM
Format:	Journal article
Language:	English
Published:	Elsevier 2022

Similar Items

Triple artemisinin-based combination therapies for malaria – a new paradigm?
by: van der Pluijm, RW, et al.
Published: (2020)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
by: Peto, TJ, et al.
Published: (2022)

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
by: Miotto, O, et al.
Published: (2020)

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
by: Tindana, P, et al.
Published: (2021)

Artemisinin and derivatives in the treatment of uncomplicated malaria.
by: White, N, et al.
Published: (1998)

Village malaria workers for the community-based management of vivax malaria
by: Adhikari, B, et al.
Published: (2022)

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
by: Paulina Tindana, et al.
Published: (2021-02-01)

Artemisinin-resistant malaria in Africa demands urgent action
by: Dhorda, M, et al.
Published: (2024)

Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
by: Thalabard Jean-Christophe, et al.
Published: (2010-02-01)

Modulation of triple artemisinin-based combination therapy pharmacodynamics by Plasmodium falciparum genotype
by: Ansbro, MR, et al.
Published: (2020)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
by: Nguyen, TD, et al.
Published: (2023)

Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
by: Nayak, S, et al.
Published: (2024)

Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar
by: Ratsimbasoa Arsène, et al.
Published: (2007-05-01)

WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria
by: Peto, TJ, et al.
Published: (2023)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
by: Zhu, L, et al.
Published: (2022)

Are national treatment guidelines for falciparum malaria in line with WHO recommendations and is antimalarial resistance taken into consideration? – A review of guidelines in non-endemic countries
by: Visser, MT, et al.
Published: (2022)

Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria
by: Florian Kurth, et al.
Published: (2016-08-01)

Artemisinin resistance in falciparum malaria
by: Dondorp, A
Published: (2012)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
by: Dondorp, A, et al.
Published: (2009)

Effectiveness and safety of 3 and 5 day courses of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar
by: Tun, KM, et al.
Published: (2018)

Single dose artemisinin-mefloquine treatment for acute uncomplicated falciparum malaria.
by: Tran, T, et al.
Published: (1994)

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
by: Srisutham, S, et al.
Published: (2022)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos.
by: Mayxay, M, et al.
Published: (2012)

Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria
by: Dinkorma T. Ouologuem, et al.
Published: (2018-12-01)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
by: Mayxay Mayfong, et al.
Published: (2012-06-01)

Investigating the efficacy of triple artemisinin-based combination therapies (TACTs) for treating Plasmodium falciparum malaria patients using mathematical modelling
by: Dini, S, et al.
Published: (2018)

Efficacy and Safety of Artemisinin-Piperaquine for the Treatment of Uncomplicated Malaria: A Systematic Review
by: Qi Wang, et al.
Published: (2020-09-01)

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
by: White, NJ
Published: (2019)

Assessment in vitro of the antimalarial and transmission-blocking activities of cipargamin and ganaplacide in artemisinin-resistant Plasmodium falciparum
by: Yipsirimetee, A, et al.
Published: (2022)

Efficacy of three artemisinin combination therapies for the treatmentof uncomplicated <it>Plasmodium falciparum </it>malaria in the Republic of Congo
by: Libama François, et al.
Published: (2006-11-01)

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
by: Smithuis, F, et al.
Published: (2010)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
by: Zhu, L, et al.
Published: (2018)

Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana
by: Samuel Yao Ahorhorlu, et al.
Published: (2023-02-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania
by: Mandike Renata, et al.
Published: (2007-11-01)

Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
by: Van Anh Thi Cao, et al.
Published: (2023-10-01)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
by: Zhu, Lei, et al.
Published: (2019)

Village malaria workers for the community-based management of vivax malaria
by: Bipin Adhikari, et al.
Published: (2023-02-01)

Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea
by: Wendy A Davis, et al.